Physician profile
William Rate
NPI 1548249287
$3,355.26
in general payments reported to CMS, 2019-2025
9 companies · $1,476 in 2025
The $1,476 reported for 2025 was more than what 87% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $1,000 · 2022: $345 · 2023: $36.31 · 2024: $365 · 2025: $1,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,877.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,635.03 | 2022-2025 | T2 Alpha, Inbone, Mako |
| Icad, INC | $1,000.00 | 2020 | |
| Depuy Synthes Sales INC. | $304.50 | 2025 | Vivigen Mis Delivery System, Tfn-Advance |
| Bone Support INC. | $282.99 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Siemens Medical Solutions USA, INC. | $57.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $31.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.84 | 2019 | |
| Seagen INC. | $15.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.